Putnam Associates at a Glance


  • "Great culture, location, dedicated, warm, and happy colleagues."
  • "Interesting cases, great colleagues, opportunity for growth."
  • "Challenging work with high impact."


  • "There are no support staff for project work."
  • "Long and sometimes unpredictable hours."
  • "Occasional crunches, pace of projects."

The Buzz

  • "Growing; Nice."
  • "Strong in healthcare."
  • "Solid for a small firm."
  • "Heard about nice experiences from friends who work there; work-life balance seems to be very good among consulting firms."

About Putnam Associates

For over 25 years, Putnam Associates has developed its niche as a premier strategy consulting firm serving pharmaceutical, biotechnology, diagnostics, medical device, and related clients in the healthcare space. The firm provides objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle. Putnam's biopharmaceutical clients range from venture-backed biotechs to large pharmaceutical, medical device, and diagnostic companies, including 14 of the top-20 global biopharmaceutical companies-indeed, despite being based in the US, half of Putnam's projects in 2014 were global in focus. 

The firm's VC and private equity work serves some of the most renowned firms in the investor community, and its projects span the globe and the product lifecycle from assets in clinical development to established brands. Putnam has served many of its core clients for more than a decade, while continuing to add new clients, major drivers of recent and future growth. 

Product placement

Given its exclusive focus on life sciences, most of Putnam's services focus on maximizing clients' investment in new and existing products. That's good news for the firm's clients, who can spend more than 10 years developing new products-including wading through discovery, comprehensive testing, regulatory reviews, and market research-before the products are launched. 

Putnam works with clients to develop strategies based on rigorous issue framing and data-driven analyses, often combining academic literature (epidemiological, clinical), third-party data (claims data, prescribing data), financial reporting data, and primary research conducted through Putnam's extensive global network of physicians, managed care organizations, hospitals, pharmacies, wholesalers and government representatives. Services in this segment include market opportunity evaluations, competitive landscape assessments, product development strategies, in-licensing assessments, product positioning and marketing, launch and growth strategies, pricing and contracting strategies, sales force effectiveness and product lifecycle planning. 

Committed to long-term relationships

By providing clients with both insight and long-term support, Putnam has become the strategic partner of choice to a growing roster of clients-with many individual relationships stretching back a decade or more. That long-term commitment also goes for the firm's employees; rather than being a landing spot for a year or two, the firm wants employees to see the potential for a longer-term career at Putnam. Accordingly, the firm is dedicated to providing both formal and informal mentorship, and supports an enriching professional culture, all in the name of fostering a collegial environment. Specific initiatives include an internal weekly seminar series to keep teams connected with one another, with advances in project methodology and new developments in health care. Mentorship, training, and tuition reimbursement programs encourage employees to continue learning. In addition, Putnamites can be found at annual national medical conferences in oncology, transplantation and other therapeutic areas, ensuring that the firm stays on the cutting edge of the latest industry trends. Putnam maintains a prominent thought-leadership profile in the industry by creating focused knowledge development presentations that can be shared with selected clients, and by sharing insights more broadly via white papers, guest lectures, and conference panel participation. 

The firm's commitment to junior employee development is evidenced by its outstanding track-record in getting these employees into top-tier MBA programs. It has achieved 100% placement success in recent years, and in the past two years alone the firm has sent multiple employees to programs at Harvard/HBS, MIT/Sloan, UPenn/Wharton and Stanford/GSB. Additionally, several recent MBA graduates have elected to take advantage of the firm's recently expanded sponsorship program and return to Putnam as Senior Consultants. Further evidence of that long-term commitment to employees can be found in the fact that more than half of the Partners and Principals at the firm started at Putnam as entry-level employees. 

Ensuring a successful launch

Nearly half of Putnam's projects in the past year have dealt with the challenge of bringing cutting edge medical innovations to market. Often an asset in development has multiple potential indications (e.g., treatment of particular types of immune disorders or different types of cancers). In one recent project, Putnam helped validate the epidemiology of untreated patient populations, then worked with the client to better define the real unmet medical needs in the therapeutic area, leading to recommendations around pivotal Phase III trial designs. Putnam then worked with the commercial team to build strategies around introducing the product to target markets, pricing the product, and attaining reimbursement. At the same time, Putnam helped build forecast models for key countries, and conducted pipeline assessments to help the client keep apace of fast moving clinical developments among competitors and to consider potential complementary in-licensing opportunities (complementary products for different subpopulations, or for combination therapies). 

The field of life sciences is exceptionally complex and fast paced. Whether Putnam's clients are evaluating their portfolios, developing new products, trying to grow marketed products, or trying to optimize late life-cycle products, the firm's strength lies in its ability to consistently deliver exceptional work and superior insights on the industry's complex challenges. 


June 2015

Putnam Holds Advanced Consulting Skills Training

Putnam conducted an all-day Advanced Consulting Skills Training offsite at the Boston Harbor Hotel for Senior Associate and Life Sciences Consultants.  The goal of the day was to build upon the training consultants have already received and expand their leadership and communication skills as well as to equip them with the tools they need to be an effective case team leader.  Last Fall, Putnam offered its 2-day Case Leadership Training Offsite in Chatham, MA, a key step in expanding training programs for senior staff.  The objective for this training program is to provide advanced practical insights and tools for case team leaders - most with significant on-the-job experience - in a structured, highly interactive way.  Modules cover all aspects of advanced problem structuring, team leadership, coaching junior staff, storyline development, client communication, and client development.  

April 2015

Putnam Opens New Office in San Francisco

We are excited to share that the firm has established an office in San Francisco.  Having a stronger presence on the west coast will allow us to expand our ability to provide world-class strategic support and insight to current and future clients. Ranked along with Boston as one the top life sciences clusters, we believe this step will offer exciting opportunities for continued business growth and recruiting.   The office has 4 employees and is growing!  The team members will serve both west coast clients, and other firm cases throughout the country. 

April  2015

Putnam Hosts Open House and Alumni Receptions in Boston, San Francisco & Chicago

Putnam wrapped up the celebration of our new office opening at Copley Square with an Open House and Alumni Reception.  The event, a wine tasting set up with help from the Boston Wine School, featured two wines made by Putnam Alumnus Jordan Kivelstadt, owner of Kivelstadt Cellars and CEO of Free Flow Wines, paired cheeses, fine hors d'oeuvres and the chance for camaraderie with many old friends.  A charity raffle at the event raised $600 for the Dana Farber Cancer Center. Putnam also hosted Alumni Dinners in Chicago and San Francisco, bringing alumni together for an evening of networking and connection. 

February 2015

Putnam Opens New Office in Boston's Back Bay 

This winter, Putnam announced the opening of our new office in Boston at 501 Boylston Street, just across from Copley Square, a few blocks from Boston Common.  The new office features a modernized build-out, complete with ample collaboration space and conference rooms to host client meetings, enhance client interaction, and supports the firm's continued growth.  

Being in Copley Square will also put Putnam closer to the foremost hubs of biotechnology innovation in Cambridge and around Boston's Longwood complex of leading research and clinical institutions.  This move allows the firm to continue to expand our ability to provide world-class strategic support and insight to our clients in the biopharmaceutical and medical device industries.

- Show Less + Show Full Description

Putnam Associates

501 Boylston Street
Boston, MA 02116
Phone: (617) 456-5200
Fax: (617) 849-7489
Vault ID: 27918


  • Employer Type: Private
  • Partner, Boston Office Head: Remco op den Kelder
  • 2015 Employees: 77

  • Employment Contact

  • Major Departments & Practices
    Corporate Strategy
    Established Product & Franchise Strategy
    New Products Strategy
    Portfolio, Licensing & Development Strategy
    Pricing, Reimbursement, & Market Access 

Major Office Locations

  • Boston, MA (HQ)
  • San Francisco, CA

Career Update Newsletter

Tips and tools to help you manage your ideal career.